VestGen Advisors »

Abcellera Biologics shares owned by VestGen Advisors

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by VestGen Advisors from 13F filings

Historical chart of VestGen Advisors investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by VestGen Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by VestGen Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $92k 19k 4.95

More positions owned by VestGen Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Gaming & Leisure Pptys (GLPI)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A Call Option (META)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for VestGen Advisors

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Ubs Global Asset Management Americas
Leucadia National Corporation
UBS Group
Arrowpoint Asset Management
BlackRock
Driehaus Capital Management
Goldman Sachs Group
Bank of America Corporation
Alyeska Investment Group
Renaissance Technologies
Tudor Investment Corporation

View all funds holding Abcellera Biologics